An understanding of transcriptional regulation is fundamental to elucidation of cellular controls during normal growth and during transformation. A unique feature of the E2F transcription factor is the regulation of activity by both viral and cellular signals. E2F activity is markedly increased in response to adenovirus infection. In addition, E2F is involved in the transcriptional response to cellular differentiation and proliferative signals, and E2F sites are present in several oncogenes and in other genes critical for cell growth. Understanding the molecular basis of E2F function could provide new insights into both cellular and viral transcriptional regulation. The adenovirus regulation of E2F provides an intriguing system in which the activity of a single transcription factor can be regulated by two distinct mechanisms. E2F is regulated by the adenovirus E1A and E4 proteins and utilizes both post-translational modification and protein-protein interactions, respectively. The experiments in this proposal are designed to probe the function and adenovirus regulation of E2F on the molecular and biochemical level. A first objective is a genetic dissection of the protein domains required for E2F function and regulation. A chief advantage of E2F is the availability of several well-characterized in vitro assays to rapidly score DNA binding, transcriptional activation, protein-protein interactions, and phosphorylation. A second objective is an assessment of the role of phosphorylation in modulating E2F activity in vivo. It has been demonstrated that phosphorylation is required for E2F activation in vitro, but the functional role in vivo is unknown. In vivo phosphorylation will be determined by immunoprecipitation of E2F from both 32P-labelled HeLa cells and then subsequent analysis be compared in nuclear extracts from both uninfected and infected HeLa cells. In conjunction with mutational analysis, the functional significance of phosphorylation sites can be assessed both in vivo and in vitro.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM044634-03
Application #
3303848
Study Section
Molecular Biology Study Section (MBY)
Project Start
1991-05-01
Project End
1996-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Berasi, Stephen P; Xiu, Mei; Yee, Amy S et al. (2004) HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase. Mol Cell Biol 24:3011-24
Yee, Amy S; Paulson, Eric K; McDevitt, Michael A et al. (2004) The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression. Gene 336:1-13
Xiu, Mei; Kim, Jiyoung; Sampson, Ellen et al. (2003) The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation. Mol Cell Biol 23:8890-901
Hassan, Waleed N; Cantuti-Castelevetri, Ippolita; Denisova, Natalia A et al. (2002) The nitrone spin trap PBN alters the cellular response to H(2)O(2): activation of the EGF receptor/ERK pathway. Free Radic Biol Med 32:551-61
Sampson, E M; Haque, Z K; Ku, M C et al. (2001) Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J 20:4500-11
Shih, H H; Xiu, M; Berasi, S P et al. (2001) HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue. Mol Cell Biol 21:5723-32
Yee, A S; Shih, H H; Tevosian, S G (1998) New perspectives on retinoblastoma family functions in differentiation. Front Biosci 3:D532-47
Gartel, A L; Goufman, E; Tevosian, S G et al. (1998) Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins. Oncogene 17:3463-9
Shih, H H; Tevosian, S G; Yee, A S (1998) Regulation of differentiation by HBP1, a target of the retinoblastoma protein. Mol Cell Biol 18:4732-43
Tevosian, S G; Shih, H H; Mendelson, K G et al. (1997) HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev 11:383-96

Showing the most recent 10 out of 15 publications